metastatic castration-resistant prostate cancer (mCRPC)

You have access
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of ¹⁷⁷Lu-PSMA I&T
Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher

Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
You have access
A Single-Arm, Low-Dose, Prospective Study of ¹⁷⁷Lu-EB-PSMA Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
Guochang Wang, Jie Zang, Yuanyuan Jiang, Qingxing Liu, Huimin Sui, Rongxi Wang, Xinrong Fan, Jingjing Zhang, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine April 1, 2023, 64 (4) 611-617; DOI: https://doi.org/10.2967/jnumed.122.264857
You have access
¹⁷⁷Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
Amir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher

Journal of Nuclear Medicine March 1, 2023, 64 (3) 402-409; DOI: https://doi.org/10.2967/jnumed.122.264402
You have access
¹⁷⁷Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer
Jie Zang, Qingxing Liu, Huimin Sui, Rongxi Wang, Orit Jacobson, Xinrong Fan, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1772-1778; DOI: https://doi.org/10.2967/jnumed.120.242263

Main menu

User menu

Search

metastatic castration-resistant prostate cancer (mCRPC)